
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Stoke Therapeutics
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an entirely new approach to treating severe diseases. We are initially focused on diseases of the central nervous system and the eye, with an emphasis on haploinsufficiencies, which are diseases caused by a loss of about half of the normal protein function. Rather than replace, repair or edit faulty genes, we aim to increase or stoke protein output from healthy genes to restore functional protein levels using our proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform. In all, Stoke has identified ~6500 genes with a TANGO signature, representing broad potential for our approach to help people with severe diseases. The early results have been promising. Stokes first medicine in development, STK-001 has demonstrated positive Phase 1/2 results for the treatment of Dravet syndrome, a severe and progressive genetic e...
C-Level 0 | VP - Level- |
Director- | Manager8 |
Others91 |
Structure | Email Format |
---|---|
<f><last>@ |
|
<first>@ | John@stoketherapeutics.com |
<last>_<first>@ | Smith_John@stoketherapeutics.com |
Pain Points | Locations | Technologies |
---|---|---|
Application Development | Cambridge, MA | communication, quality assurance, gmp, compliance, collaboration, forecasting, inventory management, risk, cgmp, simulation |
Artificial Intelligence | Cambridge, MA | ml, programming language, communication, operating procedures, sas, archival, integrity, gmp, compliance, r, collaboration, risk, data management, continuous improvement, operations, scope |
Build & Release | Bedford, MA | communication, integrity, operating procedures, compliance, testing, collaboration, security |
Build & Release | Cambridge, MA | sas, quality assurance, compliance, simulation, ml, programming language, communication, operating procedures, integrity, assessment, archival, inventory management, scope, r, collaboration, rfp, infrastructure, gmp, financial, e, forecasting, risk, data management, continuous improvement, operations |
Compliance | Bedford, MA | communication, integrity, operating procedures, compliance, testing, collaboration, security |
Collaborator
Gcp
Access
Board
Director
Archival
Assessment
Cgmp
Collaboration
Communication
About Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreAbout Stoke:Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing...
View MoreStoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an entirely new approach to treating severe diseases. We are initially focused on diseases of the central nervous system and the eye, with an emphasis on haploinsufficiencies, which are diseases caused by a loss of about half of the normal protein function. Rather than replace, repair or edit faulty genes, we aim to increase or stoke protein output from healthy genes to restore functional protein levels using our proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) platform. In all,...
Stoke therapeutics operates in the Biotechnology research industry.
Stoke therapeutics's revenue is 1b+
Stoke therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.